Double-endoscope assisted endoscopic submucosal dissection for treating tumors in rectum and distal colon by expert endoscopists: a feasibility study

• Published in: Techniques in coloproctology 2020-12, Vol.24 (12), p.1293-1299
• Main Authors: Ebigbo, A., Tziatzios, G., Gölder, S. K., Probst, A., Messmann, H.
• Format: Article
• Language: English
• Subjects: Abdominal Surgery; Aged; Colon; Colorectal Neoplasms; Colorectal Surgery; Endoscopes; Endoscopic Mucosal Resection - adverse effects; Endoscopy; Feasibility Studies; Gastroenterology; Humans; Intestinal Mucosa; Medicine; Medicine & Public Health; Middle Aged; Multimedia; Multimedia Article; Neoplasm Recurrence, Local; Proctology; Rectum; Retrospective Studies; Surgery; Treatment Outcome
• ISSN: 1123-6337; 1128-045X
• DOI: 10.1007/s10151-020-02308-4

Background Colorectal endoscopic submucosal dissection (ESD) is an effective but challenging procedure. To facilitate ESD, several methods that apply traction are available; however, the optimal one remains to be established. The aim of this study was to evaluate the feasibility and safety of the double-endoscope assisted ESD (DEA-ESD) by improving traction to treat complex colorectal lesions. Methods Naïve or previously treated lesions in the rectum and sigmoid colon were included. A grasping forceps advanced through a small-caliber endoscope (GIF-XP190N, Olympus Medical Systems, Tokyo, Japan, 5.4 mm outer diameter) was used to apply traction to the mucosal flap. Lesions were deemed complex when they exceeded a total of nine points on the SMSA scoring system (size, morphology, site, and access) and recurrent when they were previously treated with endoscopic mucosal resection (EMR). Outcome measures included procedural success, total procedure time, complications, and recurrence rate at 3-month follow-up. Results Nine patients (mean age 62.3 ± 14.5 years) were included; five had rectal and four had tumors in the sigmoid colon. The median SMSA score was 14 (SMSA Level IV—complex polyp), while three patients were pre-treated with EMR. DEA-ESD was technically feasible in all cases. En bloc resection and R0 resection rates were 100%, respectively, with a mean procedure time of 128.4 ± 54.1 min. No immediate or delayed complications occurred. Conclusions DEA-ESD is a feasible and safe method for treating complex or recurrent tumors in the rectum and distal colon.